Immunoadsorption of alloantibodies onto erythroid membrane antigens encapsulated into polymeric microparticles

Pharmaceutical Research

Volumn 24, Issue 11, 2007, Pages 2055-2062

  Hoffart, Valérie ^a   Maincent, Philippe ^a   Lamprecht, Alf ^b   Latger Cannard, Véronique ^c   Regnault, Véronique ^c   Merle, Christian ^d   Jouan Hureaux, Valérie ^a   Lecompte, Thomas ^c   Vigneron, Claude ^a   Ubrich, Nathalie ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b Laboratory of Pharmaceutical Engineering   (France)

^c INSERM   (France)

^d Laboratory of Industrial Pharmacy   (France)

Author keywords

Alloantibodies; Biomaterials; Immunoadsorption; Microparticles; Red blood cell antigens

Indexed keywords

ALLOANTIBODY; BIOMATERIAL; BLOOD GROUP A ANTIBODY; BUFFER; HYPOTONIC SOLUTION; MEMBRANE ANTIGEN; POLYCLONAL ANTIBODY; POLYMER; PROTEIN;

ADSORPTION KINETICS; ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; CHROMATOGRAPHY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG DESIGN; ERYTHROCYTE; ERYTHROID CELL; HUMAN; HUMAN CELL; IMMUNOADSORPTION; MICROENCAPSULATION; PARTICLE SIZE; PLASMA; POROSITY; PRIORITY JOURNAL; PROTEIN CONTENT; TOXICITY;

ABO BLOOD-GROUP SYSTEM; CELLULOSE; ERYTHROCYTE MEMBRANE; FLOW CYTOMETRY; HUMANS; IMMUNOSORBENTS; ISOANTIBODIES; ISOANTIGENS; KELL BLOOD-GROUP SYSTEM;

EID: 34848839221     PISSN: 07248741     EISSN: 1573904X     Source Type: Journal    
DOI: 10.1007/s11095-007-9340-2     Document Type: Article

References (29)

1. R. Bambauer. Low-density lipoprotein apheresis: clinical results with different methods. Artif. Organs 26:133-139 (2002).
2. A. Y. Hershko and Y. Naparstek. Removal of pathogenic autoantibodies by immunoadsorption. An. New York Acad. Sci. 1051:635-646 (2005).
3. H. Zeitler, G. Ulrich-Merzenich, P. Walger, H. Vetter, J. Oldenburg, G. Goldmann, and H. H. Brackmann. Treatment of factor VIII inhibitors with selective IgG immunoadsorption-a single center experience in 50 patients with acquired hemophilia. Transfus. Med. Hemother. 33(2):160-164 (2006).
4. K. Laczika, S. Knapp, K. Derfler, A. Soleiman, W. H. Hörl, and W. Druml. Immunoadsorption in Goodpasture's syndrome. Am. J. Kidney Dis. 36:392-395 (2000).
5. S. Schmaldienst, M. Jansen, U. Hollenstein, W. Graninger, H. Regele, W. H. Hörl, and K. Derfler. Treatment of systemic lupus erythematosus by immunoadsorption in a patient suffering from tuberculosis. Am. J. Kidney Dis. 39:415-418 (2002).
6. G. A. Bohmig, H. Regele, and M. Exner. C4d-positive acute humoral renal allograft rejection: effective treatment by immunoadsorption. J. Am. Soc. Nephrol. 12:2482-2489 (2001).
7. R. M. Higgins, D. J. Bevan, B. S. Carey, C. K. Lea, M. Fallon, R. Bühler, R. W. Vaughan, P. J. O'Donnell, S. A. Snowden, M. Bewick, and B. M. Hendry. Prevention of hyperacute rejection by removal of antibodies to HLA immediately before renal transplantation. Lancet 348:1208-1211 (1996).
8. N. Braun, J. N. Kadar, and T. Risler. Therapeutic immunoadsorption-its role in clinical practice. Transfus. Sci. 19:65-69 (1998).
9. U. Heidrun and P. Kuehnl. New trends in specific immunoadsorption. Transf. Apheresis Sci. 30:223-231 (2004).
10. J. M. Schneidewind-Müller, R. E. Winkler, M. Tiess, W. Müller, and W. Ramlow. Changes in lymphocytic cluster distribution during extracorporeal immunoadsorption. Artif. Organs 26:140-144 (2002).
11. M. Koch and R. Trapp. Ethyl mercury poisoning during a protein A immunoadsorption treatment. Am. J. Kidney Dis. 47(2):31-34 (2006).
12. H. Bessos, C. Appleyard, L. R. Micklem, and D. C. Pepper. Monoclonal antibody leakage from gels: effects of support, activation and eluent composition. Prep. Chromat. 1:207-220 (1991).
13. B. R. Gordon, B. J. Sloan, T. S. Parker, S. D. Saal, D. M. Levine, and A. L. Rubin. Humoral immune response following extracorporeal immunoadsorption therapy of patients with hypercholesterolemia. Transfusion 30:327-332 (1990).
14. N. Ubrich, J. Ngondi, C. Rivat, M. Pfister, C. Vigneron, and P. Maincent. Selective in vitro removal of anti-A antibodies by adsorption on encapsulated erythrocyte-ghosts. J. Biomed. Mater. Res. 37:155-160 (1997).
15. N. Ubrich, C. Rivat, C. Vigneron, and P. Maincent. Microporous microparticles designed as stable immunoadsorbents. Biotech. Bioeng. 58:581-586 (1998).
16. ® immunoadsorption. Bone Marrow Transpl. 32:1015-1019 (2003).
17. J. T. Dodge, C. Mitchell, and D. J. Hanahan. The preparation and chemical characteristics of hemoglobin free ghosts of human erythrocytes. Arch. Biochem. Biophys. 100:119-130 (1963).
18. P. K. Smith, R. I. Krohn, G. T. Hermanson, A. K. Mallia, F. H. Gartner, M. D. Provenzano, E. K. Fujimoto, N. M. Goeke, B. J. Olson, and D. C. Klenk. Measurement of protein using bicinchoninic acid. Anal. Biochem. 150:76-85 (1985).
19. S. Mattsson and C. Nyström. The use of mercury porosimetry in assessing the effect of different binders on the pore structure and bonding properties of tablets. Eur. J. Pharm. Biopharm. 52:237-247 (2001).
20. S. P. Rigby, D. Barwick, R. S. Fletcher, and S. N. Riley. Interpreting mercury porosimetry data for catalyst supports using semi-empirical alternatives to the Washburn equation. Appl. Catalysis A: General 238:303-318 (2003).
21. A. E. Clausen and A. Bernkop-Schnürch. In vitro evaluation of the permeation enhancing effect of thiolated polycarbophil. J. Pharm. Sci. 89:1253-1261 (2000).
22. T. L. Steck and J. A. Kant. Preparation of impermeable ghosts and inside-out vesicles from human erythrocyte membranes. In S. Fleicher (ed.), Methods in Enzymology, Part A, Vol. 31, Elsevier, Amsterdam, 1974, pp. 172-180.
23. A. J. Schroit and R. F. A. Zwaal. Transbilayer movement of phospholipids in red cell and platelet membranes. Biochim. Biophys. Acta 1071:313-329 (1991).
24. F. Ruspini, N. Petitpain, M. Marchand-Arvier, C. Vigneron, and C. Janot. Antigen blood group maintenance on freeze-dried erythrocytes and ghosts after their isolation. Vox Sang. 68:105-108 (1995).
25. H. Yushu and S. Venkatraman. The effect of process variables on the morphology and release characteristics of protein-loaded PLGA particles. J. Appl. Polym. Sci. 101:3053-3061 (2006).
26. D. Klose, F. Siepmann, K. Elkharraz, S. Krenzlin, and J. Siepmann. How porosity and size affect the drug release mechanisms from PLGA-based microparticles. Int. J. Pharm. 314:198-206 (2006).
27. J. P. Cartron and Y. Colin. Structural and functional diversity of blood group antigens. Transfus. Clin. Biol. 8:163-199 (2001).
28. J. G. Kadar, M. Parusel, and P. J. Spaeth. Immunological effects of therapeutic immunoadsorption with respect to biocompatibility. Transfus. Sci. 19:9-23 (1998).
29. T. Bosch, B. Schmidt, M. Blumenstein, and H. J. Gurland. Lipid apheresis by hemoperfusion: in vitro efficacy and ex vivo biocompatibility of a new low density lipoprotein adsorber compatible with human whole blood. Artif. Organs 17:640-652 (1993).